120
Participants
Start Date
March 1, 2019
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
Paclitaxel for Injection（Albumin Bound）
Patients firstly receive nab-paclitaxel 100 mg/m\^2 (iv, 30 minutes) on days 1, 8, and 15 for 3 weeks, followed by one week without treatment. Treatment repeats every 4 weeks until the disease recurrence or unacceptable toxicity，death or begin a novel therapeutic.
Gemcitabine
Patients secondly receive gemcitabine 1000 mg/m\^2 (iv, 30 minutes) on days 1, 8, and 15 for 3 weeks, followed by one week without treatment. Treatment repeats every 4 weeks until the disease recurrence or unacceptable toxicity，death or begin a novel therapeutic.
RECRUITING
FUDAN University, Shanghai
Collaborators (1)
Fudan University
OTHER
CSPC Ouyi Pharmaceutical Co., Ltd.
INDUSTRY